343 related articles for article (PubMed ID: 19881343)
1. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.
Koo HL; DuPont HL
Curr Opin Gastroenterol; 2010 Jan; 26(1):17-25. PubMed ID: 19881343
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
DuPont HL; Jiang ZD; Okhuysen PC; Ericsson CD; de la Cabada FJ; Ke S; DuPont MW; Martinez-Sandoval F
Ann Intern Med; 2005 May; 142(10):805-12. PubMed ID: 15897530
[TBL] [Abstract][Full Text] [Related]
3. Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections.
Gerard L; Garey KW; DuPont HL
Expert Rev Anti Infect Ther; 2005 Apr; 3(2):201-11. PubMed ID: 15918778
[TBL] [Abstract][Full Text] [Related]
4. Rifaximin: a nonabsorbed oral antibiotic.
Baker DE
Rev Gastroenterol Disord; 2005; 5(1):19-30. PubMed ID: 15741929
[TBL] [Abstract][Full Text] [Related]
5. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.
Cottreau J; Baker SF; DuPont HL; Garey KW
Expert Rev Anti Infect Ther; 2010 Jul; 8(7):747-60. PubMed ID: 20586560
[TBL] [Abstract][Full Text] [Related]
6. Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders.
Adachi JA; DuPont HL
Clin Infect Dis; 2006 Feb; 42(4):541-7. PubMed ID: 16421799
[TBL] [Abstract][Full Text] [Related]
7. What's new in enteric infectious diseases at home and abroad.
DuPont HL
Curr Opin Infect Dis; 2005 Oct; 18(5):407-12. PubMed ID: 16148527
[TBL] [Abstract][Full Text] [Related]
8. Rifaximin: a nonabsorbed antimicrobial as a new tool for treatment of travelers' diarrhea.
Steffen R
J Travel Med; 2001 Dec; 8(Suppl 2):S34-9. PubMed ID: 12186672
[No Abstract] [Full Text] [Related]
9. Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy.
Infante RM; Ericsson CD; Jiang ZD; Ke S; Steffen R; Riopel L; Sack DA; DuPont HL
Clin Gastroenterol Hepatol; 2004 Feb; 2(2):135-8. PubMed ID: 15017618
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.
Taylor DN; Bourgeois AL; Ericsson CD; Steffen R; Jiang ZD; Halpern J; Haake R; Dupont HL
Am J Trop Med Hyg; 2006 Jun; 74(6):1060-6. PubMed ID: 16760520
[TBL] [Abstract][Full Text] [Related]
11. Rifaximin for the treatment of acute infectious diarrhea.
Hong KS; Kim JS
Therap Adv Gastroenterol; 2011 Jul; 4(4):227-35. PubMed ID: 21765867
[TBL] [Abstract][Full Text] [Related]
12. Rifaximin--a novel antimicrobial for enteric infections.
Huang DB; DuPont HL
J Infect; 2005 Feb; 50(2):97-106. PubMed ID: 15667909
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis.
Alajbegovic S; Sanders JW; Atherly DE; Riddle MS
Syst Rev; 2012 Aug; 1():39. PubMed ID: 22929178
[TBL] [Abstract][Full Text] [Related]
14. Rifaximin: a new treatment for travelers' diarrhea.
Pakyz AL
Ann Pharmacother; 2005 Feb; 39(2):284-9. PubMed ID: 15598963
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Hu Y; Ren J; Zhan M; Li W; Dai H
J Travel Med; 2012 Dec; 19(6):352-6. PubMed ID: 23379704
[TBL] [Abstract][Full Text] [Related]
16. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
Dupont HL; Jiang ZD; Belkind-Gerson J; Okhuysen PC; Ericsson CD; Ke S; Huang DB; Dupont MW; Adachi JA; De La Cabada FJ; Taylor DN; Jaini S; Martinez Sandoval F
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):451-6. PubMed ID: 17382603
[TBL] [Abstract][Full Text] [Related]
17. Use of rifaximin in gastrointestinal and liver diseases.
Shayto RH; Abou Mrad R; Sharara AI
World J Gastroenterol; 2016 Aug; 22(29):6638-51. PubMed ID: 27547007
[TBL] [Abstract][Full Text] [Related]
18. Therapy of travelers' diarrhea with rifaximin on various continents.
Steffen R; Sack DA; Riopel L; Jiang ZD; Stürchler M; Ericsson CD; Lowe B; Waiyaki P; White M; DuPont HL
Am J Gastroenterol; 2003 May; 98(5):1073-8. PubMed ID: 12809830
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of rifaximin for the prevention of travelers' diarrhea in US military personnel deployed to Incirlik Air Base, Incirlik, Turkey.
Armstrong AW; Ulukan S; Weiner M; Mostafa M; Shaheen H; Nakhla I; Tribble DR; Riddle MS
J Travel Med; 2010; 17(6):392-4. PubMed ID: 21050319
[TBL] [Abstract][Full Text] [Related]
20. Current concepts in travelers' diarrhea: epidemiology, antimicrobial resistance and treatment.
Okhuysen PC
Curr Opin Infect Dis; 2005 Dec; 18(6):522-6. PubMed ID: 16258326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]